Results 131 to 140 of about 24,190 (185)

Laser-Assisted OPN Technique for Recalcitrant Multilayer In-Stent Restenosis: A Systematic Approach. [PDF]

JACC Case Rep
Majwal O, Quan VH, Avram R, Nosair M.
europepmc   +1 more source

Rationale and design of a multicenter, prospective, diagnostic clinical study: A study protocol for evaluating the diagnostic validation of deep learning-based noninvasive CT-FFR for in-stent restenosis. [PDF]

PLoS One
Liu S, Sun M, Ma Z, Nie Y, Zhang B, Xue Y, Zhang M, Zhang M, Chen H, Song X, Zhang D.   +10 more
europepmc   +1 more source

From Caging to Uncaging With Bioadaptors: A Novel Paradigm in Coronary Revascularization. [PDF]

J Am Heart Assoc
Mazzone PM, Spagnolo M, Finocchiaro S, Mauro MS, Di Leo G, Capodanno D.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Coronary In-Stent Restenosis

Journal of the American College of Cardiology, 2022
Samin Sharma
exaly   +2 more sources

Restenosis following coronary angioplasty

The International Journal of Cardiac Imaging, 1990
The assessment of restenosis following angioplasty has become increasingly important in determining the clinical value of the procedure. Despite this there has been no uniformly accepted methodology for assessing the procedure and consequently the published results have often been misleading with little concensus.
K J, Beatt, P W, Serruys
openaire   +4 more sources

Coronary Restenosis

Journal of the American Academy of Nurse Practitioners, 1996
Return of angina within 6 months of a catheter-based treatment of coronary artery disease usually reflects restenosis due to an overly aggressive local healing response to the procedure-related arterial injury. The restenotic lesion should be treated aggressively.
C, Brown, L, Clark, L, Williams, S, Gallagher, M, Levesque, J, Silva   +5 more
openaire   +2 more sources

Prevention of Coronary Restenosis

Cardiology in Review, 1999
Percutaneous transluminal coronary angioplasty (PTCA) was introduced 22 years ago as a nonsurgical catheter-based treatment for obstructive coronary artery disease. Over the following 2 decades, major advances in equipment and techniques led to tremendous growth in the use of PTCA to treat coronary artery disease and angina.
P J, Casterella, P S, Teirstein
openaire   +2 more sources

Costs of coronary restenosis (Lovastatin Restenosis Trial)

The American Journal of Cardiology, 1996
Within the Lovastatin Restenosis Trial, restenosis has been clearly shown to increase resource utilization and costs. While it is not possible to generalize these results to other patient populations, it is clear that successful efforts to decrease restenosis will certainly improve efficacy while decreasing follow-up costs and increasing the cost ...
S P, Gilbert, W S, Weintraub, J D, Talley, S J, Boccuzzi   +3 more
openaire   +2 more sources

Coronary dissection: A predictor of restenosis?

American Heart Journal, 1988
To determine if arterial dissection resulting from transluminal coronary angioplasty (TCA) leads to a greater incidence of restenosis, 273 consecutive patients who had undergone TCA with at least 1 year of follow-up were examined. Success was graded as a greater than or equal to 20% increase in intraluminal diameter.
B J, Matthews, C J, Ewels, K M, Kent
openaire   +2 more sources